LAB
NASD Standard BioTools Inc.$0.6578 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.6578, $0.0322 below the day’s high of $0.6900
- YTD change
- -48.61%
- vs 20-day SMA
- -9.21%
- vs 200-day SMA
- -32.44%
Price ranges
Price & Performance
-0.22 (-25.46%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 84.4% away from all-time highs of $4.2300
- LAB is down 49% since the beginning of the year
- LAB is down 49% over the past 12 months
- LAB is down 5% over the past 1 month
- 1% of all LAB investors are betting against LAB
LAB reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -49.0%.
- Previous minute
- +$0.0000
- Last hour
- -$0.0078
- Last 5 days
- -11.67%
- vs 8-day SMA
- -8.27%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Standard BioTools Inc. engages in the provision of biotechnology tools and services for clinical research. It sells preparatory and analytical instruments for mass cytometry, polymerase chain reaction, library prep, single cell genomics, and consumables including integrated fluidic circuits (IFCs), assays, and reagents. The company was founded by Stephen D. Quake and Gajus Vincent Worthington on May 19, 1999 and is headquartered in Boston, MA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.